期刊文献+

肥胖对2型糖尿病患者尿白蛋白排泄的影响研究 被引量:2

Relationship Between Obesity and Excretion of Urine Protein in Type 2 Diabetics
下载PDF
导出
摘要 【目的】探讨肥胖对2型糖尿病(T2DM )患者尿白蛋白排泄的影响。【方法】选择本科收治的T2DM 患者105例,根据体质量指数(BMI ,kg/m^2)分为正常组(40例,18≤ BMI <24)、超重组(29例,24≤BMI <28)、肥胖组(36例,BMI ≥28)三组,比较三组患者24 h 尿微量白蛋白(mALB),随机尿微量白蛋白/肌酐(ACR)等相关指标水平;同时以腰臀比(WHR)分为肥胖组(51例,男 WHR >0.90,女 WHR >0.80 )、正常组(54例男 WHR ≤0.90,女 WHR ≤0.80 ),比较两组患者 mALB 、ACR 等相关指标水平。【结果】①根据BMI 分组,正常组 mALB 和 ACR 为[(100.98±70.42)mg/24 h 和(99.24±69.88)mg/g];超重组 mALB 和ACR 为[(214.37±102.69)mg/24 h 和(208.5±71.35)mg/g];肥胖组 mALB 和 ACR 为[(467.77±330.86) mg/24 h 和(424.49±131.38)mg/g];均较正常组明显升高,差异具有统计学意义( P < 0.05)。②根据 WHR分组,正常组 mALB 和 ACR 为[(132.06±98.98)mg/24 h 和(127.90±84.53)mg/g],肥胖组 mALB 和 ACR为[(406.37±312.09)mg/24 h 和(373.32±152.02)mg/g],较正常组明显升高,差异具有统计学意义( P <0.05)。【结论】mALB 、ACR 随 BMI 及 WHR 增高而增高,控制肥胖有利于预防糖尿病肾病(DN )的发生及延缓病程的进展。 [Objective] To explore the effects of obesity on excretion of urine protein in type 2 diabetics .[Methods] A total of 105 type 2 diabetics were enrolled and divided into normal weight ( n = 40 ,18 ≤ BMI 〈 24) ,over‐weight ( n = 29 ,24 ≤ BMI 〈 28) and obesity (n = 36 ,BMI ≥ 28) groups according to body mass index (BMI) .The levels of 24‐hour urine microalbumin (mAlb) and urinary albumin creatinine ratio (ACR) were compared for three groups .Also based upon waist‐hip ratio (WHR) ,they were divided into obesity ( n = 51 ,male WHR 〉 0 .90 ,female WHR 〉 0 .80) and normal control ( n = 54 ,male WHR ≤ 0 .90 ,female WHR ≤ 0 .80) groups for comparing the levels of mAlb and ACR .[Results] According to BMI ,24h Um‐Alb and ACR in overweight group (214 .37 ± 102 .69 ;208 .5 ± 71 .35)and obesity group (467 .77 ± 330 .86 ;424 .49 ± 131 .38) were markedly higher than that in normal weight group (100 .98 ± 70 .42 ;99 .24 ± 69 .88)( P 〈 0 .05) .According to WHR ,24h Um‐Alb and ACR significantly increased in obesity group versus normal control group (406 .37 ± 312 .09 ;373 .32 ± 152 .02 vs 132 .06 ± 98 .98 ;27 .90 ± 84 .53)( P 〈 0 .05) .[Conclusion]The levels of mAlb and ACR increase with greater BMI and WHR in type 2 diabetics .And obesity control may prevent the occurrence of diabetic nephropathy and delay progression .
出处 《医学临床研究》 CAS 2015年第6期1104-1106,共3页 Journal of Clinical Research
关键词 肥胖症 糖尿病 2 白蛋白尿 人体质量指数 腰臀比 糖尿病肾病/预防和控制 Obesity Diabetes Mellitus, Type 2 Albuminuria Body Mass Index Waist-HipRatio Diabetic Nephropathies/PC
  • 相关文献

参考文献11

  • 1中国成人肥胖症防治专家共识[J].中华内分泌代谢杂志,2011,27(9):711-717. 被引量:560
  • 2翟莎,周园媛,王战建.腹型肥胖和糖尿病肾病[J].中国医学前沿杂志(电子版),2012,4(9):24-27. 被引量:7
  • 3Eyileten T, $onmez A, Saglam M, et al. Effect of renin-an giotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy [J]. Nephrology (Carlton), 2010,15(2) :225-229.
  • 4张义德,刘志红,谢红浪,葛永纯,周巧玲,黎磊石.肥胖的2型糖尿病肾病患者临床及病理特点分析[J].肾脏病与透析肾移植杂志,2009,18(3):211-217. 被引量:9
  • 5Ng DP, Tai BC, Tan E, et al . Nephrinuria associates with multiple renal traits in type 2 diabetes. [J]. Nephrol Dial Transplant, 2011,26(8) :2508-2514.
  • 6Boer IH,Phil RK,Fried I.F, et al . Obesity and change in esti mated GFR among older adults[J]. Am J Kidney Dis, 2009 , 54(6), 1043-1051.
  • 7Shirakawa J, Togashi Y, Tajima K, et al . Plasminogen acti- vator inhibitor 1 is associated with renal dysfunction inde- pendent of BMI and serum lipid levels in patients with type 2 diabetes[J]. Diabetes Res Clin Pract, 2012 ,97(1) :e9-e12.
  • 8Satirapoj B, Supasyndh O, Mayteedol N, et al . Obesity and its relation to chronic kidney disease: a population-based, cross sectional study of a Thai army population and relatives [J]. Nephrology (Carlton), 2013,18(3) :229-234.
  • 9Savino A. Pelliccia P. Chiarelli F, et al . Obesity-Related Renal Injury in Childhood[J]. Horm Res paediatr, 2010, 73 (5): 303-311.
  • 10Navaneethan SD, Schold JD, Kirwan JP, et al . Metabolic syndrome, ESRD, and death in CKD [J ] . J Am Soc Nephrol, 2013,8(6) :945-952.

二级参考文献65

  • 1广东省糖尿病流行病学调查协作组.腰围/身高比值:预测糖尿病和高血压的有效的腹型肥胖指标[J].中华内分泌代谢杂志,2004,20(3):272-275. 被引量:160
  • 2陈燕,刘志红,陈慧梅,贾忠辉,王庆文,黎磊石.肥胖相关性肾病患者胰岛素抵抗状态评估指标的分析[J].肾脏病与透析肾移植杂志,2005,14(5):423-426. 被引量:3
  • 3Nielsen S,Guo Z,Johnson CM,et al.Splanchnic lipolysis in human obesity.J Clin Invest,2004,113:1582-1588.
  • 4Expert Committee on the Diagnosis and Classification of Diabetes Mellitus:Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Diabetes Care,1997,20:1183 -1197.
  • 5Levey AS,Bosch JP,Lewis JB,et al.A more accurate method to estimate glomerular filtration rate from serum creatinine:A new prediction equation.Modification of Diet in Renal Disease Study Group.Ann Intern Med,1999,130:461 -470.
  • 6Matthews DR,Hooker JP,Naylor BA,et al.Homeootasismodel assessment:insulin resistance and β cell function from fasting plasma glucose and insulin concentrations in man.Diabetolngia,1985,28:412 -419.
  • 7Gellman DD,Pirani CL,Soothill JF,Muehrcke RC,Kark RM.Diabetic nephropathy; a clinical and pathologic study based on renal biopsies.Medicine,1959,38:321 -367.
  • 8Hang D,Zheng T,Jia-qing S,et al.Nodular glomerular lesion:a hirer stage of diabetic nephropathy? Diabetes Res Clin Pract,2007,78(2):189 -195.
  • 9Bertani T,Gambam V,Remuzzi G.Structural basis of diabetic nephropathy in microulbuminuric NIDDM patients:a light microscopy study.Diabetolngia,1996,39:1625-1628.
  • 10Kahn SE,Hull RL,Utzschneider KM.Mechanisms linking obesity to insulin resistance and type 2 diabetes.Nature,2006,444:840 -846.

共引文献573

同被引文献8

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部